A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%

NCT01426867 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
DRUG: Brinzolamide ophthalmic suspension, 1%
DRUG: Brimonidine tartrate ophthalmic solution, 0.2%

Sponsor

Alcon Research